title: Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?
authors.affiliation: Department of Nuclear Medicine, University Hospital Marburg, Baldingerstraße, 35043, Marburg, Germany. verburg@med.uni-marburg.de.
authors.forename: Frederik A
authors.initials: FA
authors.lastname: Verburg
authors.affiliation: Department of Nuclear Medicine, University Hospital Marburg, Baldingerstraße, 35043, Marburg, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Luster
authors.affiliation: Department of Nuclear Medicine & Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
authors.forename: Luca
authors.initials: L
authors.lastname: Giovanella
mesh_terms: D019317:Evidence-Based Medicine; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D009683:Nuclear Medicine / Q000592:standards*; D011182:Postoperative Care / Q000592:standards*; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant / Q000592:standards; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D016896:Treatment Outcome; D014481:United States
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals